DelMar Pharmaceuticals, Inc. Analytics - Traffic, Statistics and Competitor Tracking


DelMar Pharmaceuticals, Inc. Website Screenshot

http://www.delmarpharma.com

DelMar Pharmaceuticals, Inc. Company Intro

DelMar Pharmaceuticals is developing new cancer therapies in areas where patients are failing or have become intolerable to currently available treatments.

Industry

Healthcare

DelMar Pharmaceuticals, Inc. Headquaters

12707 High Bluff Drive
San Diego,92130
United States


DelMar Pharmaceuticals, Inc. Share price

20 Oct 2020 01:29 GMT

$1.2200

-0.03 (-2.4 %)


DelMar Pharmaceuticals, Inc. Market cap

$15.354 M


WMC RANKING

2020

DelMar Pharmaceuticals, Inc. # 457

Biotechnology



Latest DelMar Pharmaceuticals, Inc. News

News 19 Oct 2020

Global Epithelial Ovarian Cancer Drugs Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2025: Celgene, Abraxane, AstraZeneca

DelMar Pharmaceuticals Inc ... In-depth company profile along with remuneration, pricing model, gross margins, and all other financial aspects are given as well.

News 19 Oct 2020

+ 20.1% CAGR of Ovarian Cancer Drug Market :Detailed ...

... Ltd, Pfizer Inc., Merck KGaA, Syndax, Clovis Oncology, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Exelixis, Inc., DelMar Pharmaceuticals ...

News 19 Oct 2020

Medulloblastoma Drug Market to Witness Remarkable Growth ...

Bayer AG, Bristol-Myers Squibb Company, DelMar Pharmaceuticals Inc, Ignyta Inc, IMPACT Therapeutics Inc, Lipocure Ltd, MacroGenics Inc, NewLink Genetics ...

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
DelMar Pharmaceuticals, Inc. 0 0 0 0 0 0 0
Alexion Pharmaceuticals, Inc. 100 11.32 100 20 0 0 96.20
Vertex Pharmaceuticals Incorporated 97.58 100 3.68 33 0 0 100
3SBio Inc. 96.05 0 0 0 0 0 0.06
Incyte Corporation 40.27 8.70 7.11 100 0 0 84.84

DelMar Pharmaceuticals, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
DelMar Pharmaceuticals, Inc. $0 $8,145 $-9,135 $15.354M 457
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $26.687B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $56.803B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥20.207B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.193B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total DelMar Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors



DelMar Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors